Showing results (171-180 of 248) with videos related to
Sort By:
Pageof 25
World Journal of Gastroenterology|March 30, 2006
Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosisMaria Rosa Biagini, Alessandro Tozzi, Rossella Marcucci, et al.Journal of the American College of Cardiology|January 22, 2008
Short- and long-term prognosis of syncope, risk factors, and role of hospital admission: results from the STePS (Short-Term Prognosis of Syncope) studyGiorgio Costantino, Francesca Perego, Franca Dipaola, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 8, 2025
Tailor-made Biochar enhances the anti-tumour effects of butyrate-glycerides in colorectal cancerLaura Fei, Arianna Pia Propato, Giulia Lotti, et al.Metabolites|October 10, 2020
Effects of Probiotics Administration on Human Metabolic PhenotypeVeronica Ghini, Leonardo Tenori, Marco Pane, et al.Journal of Hepatology|November 22, 2016
The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cellsElisabetta Ceni, Tommaso Mello, Simone Polvani, et al.Journal of Hepatology|May 28, 2014
Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinomaMirko Tarocchi, Simone Polvani, Anna Julie Peired, et al.Frontiers in Oncology|December 22, 2023
KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patientsDaniele Lavacchi, Simone Polvani, Antonio Taddei, et al.The Journal of Antimicrobial Chemotherapy|June 9, 2012
Immune recovery and T cell subset analysis during effective treatment with maravirocFrancesca Cossarini, Andrea Galli, Laura Galli, et al.Molecular and Cellular Biology|June 19, 2008
Identification of a posttranslational mechanism for the regulation of hERG1 K+ channel expression and hERG1 current density in tumor cellsLeonardo Guasti, Olivia Crociani, Elisa Redaelli, et al.AIDS (London, England)|April 8, 2021
Residual viremia in HIV-infected patients who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor based regimenNicola Gianotti, Laura Galli, Andrea Poli, et al.Pageof 25